Emilio Bertani1, Fabio Zugni2, Davide Radice3, Francesca Spada4, Guido Bonomo5, Uberto Fumagalli Romario6, Nicola Fazio4, Luigi Funicelli2. 1. Division of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti, 435, 20141, Milan, Italy. emilio.bertani@ieo.it. 2. Division of Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy. 3. Division of Epidemiology and Biostatistics, IEO, European Institute of Oncology IRCCS, Milan, Italy. 4. Division of Gastrointestinal and Neuroendocrine Tumors Medical Treatment, IEO, European Institute of Oncology IRCCS, Milan, Italy. 5. Division of Interventional Radiology, IEO, European Institute of Oncology IRCCS, Milan, Italy. 6. Division of Digestive Surgery, IEO, European Institute of Oncology IRCCS, Via G. Ripamonti, 435, 20141, Milan, Italy.
Abstract
BACKGROUND: Vascular infiltration may jeopardize resection of the primary tumor and mesenteric metastatic masses in small-intestine neuroendocrine tumors (SI-NETs). However, other factors may play a role in predicting resectability. METHODS: After computed tomography (CT) scan, three radiological parameters were considered: (1) degree of superior mesenteric artery involvement (SMA) according to a previous classification (2) degree of superior mesenteric venous involvement (SMV) as either absent, peripheral or proximal (3) presence or not of mesenteric fibrosis retraction (MF). Pre-surgical parameters were matched to surgical outcome. RESULTS: Forty-nine consecutive patients were submitted to laparotomy. Of them, 37 had complete primary tumor and mesenteric masses resection. SMA (p = 0.001), SMV (p = 0.008), metastasis site (p = 0.001) and MF (p < 0.001) were all significantly associated with the likelihood to receive resection at univariate analysis. All the five patients with infiltration of SMV proximal to middle colic vein were unresectable. At multivariable analysis excluding SMA stage, the absence of MF (HR 13.1, I.C. 1.44-119; p = 0.002) was the only factor associated with the likelihood to receive primary tumor and mesentery radical surgery. CONCLUSIONS: SMA stage 3-up and/or signs of MF, as well as infiltration of SMV proximal to middle colic vein at CT scan are predictive of operative failure in patients with SI-NETs. The assessment of such factors should be always considered in the decision-making process of such patients especially in those with asymptomatic disease with synchronous unresectable liver metastases.
BACKGROUND: Vascular infiltration may jeopardize resection of the primary tumor and mesenteric metastatic masses in small-intestine neuroendocrine tumors (SI-NETs). However, other factors may play a role in predicting resectability. METHODS: After computed tomography (CT) scan, three radiological parameters were considered: (1) degree of superior mesenteric artery involvement (SMA) according to a previous classification (2) degree of superior mesenteric venous involvement (SMV) as either absent, peripheral or proximal (3) presence or not of mesenteric fibrosis retraction (MF). Pre-surgical parameters were matched to surgical outcome. RESULTS: Forty-nine consecutive patients were submitted to laparotomy. Of them, 37 had complete primary tumor and mesenteric masses resection. SMA (p = 0.001), SMV (p = 0.008), metastasis site (p = 0.001) and MF (p < 0.001) were all significantly associated with the likelihood to receive resection at univariate analysis. All the five patients with infiltration of SMV proximal to middle colic vein were unresectable. At multivariable analysis excluding SMA stage, the absence of MF (HR 13.1, I.C. 1.44-119; p = 0.002) was the only factor associated with the likelihood to receive primary tumor and mesentery radical surgery. CONCLUSIONS: SMA stage 3-up and/or signs of MF, as well as infiltration of SMV proximal to middle colic vein at CT scan are predictive of operative failure in patients with SI-NETs. The assessment of such factors should be always considered in the decision-making process of such patients especially in those with asymptomatic disease with synchronous unresectable liver metastases.
Authors: Víctor Rodríguez Laval; Marianne Pavel; Ingo G Steffen; Alexander D Baur; Lisa M Dilz; Christian Fischer; Katharina Detjen; Vikas Prasad; Andreas Pascher; Dominik Geisel; Timm Denecke Journal: Neuroendocrinology Date: 2017-04-07 Impact factor: 4.914
Authors: Jayme E Locke; Deirdre Sawinski; Rhiannon D Reed; Brittany Shelton; Paul A MacLennan; Vineeta Kumar; Shikha Mehta; Roslyn B Mannon; Robert Gaston; Bruce A Julian; John J Carr; James G Terry; Meredith Kilgore; Allan B Massie; Dorry L Segev; Cora E Lewis Journal: Ann Surg Date: 2018-06 Impact factor: 13.787
Authors: Enes Kaçmaz; Jeffrey W Chen; Pieter J Tanis; Els J M Nieveen van Dijkum; Anton F Engelsman Journal: J Neuroendocrinol Date: 2021-07-08 Impact factor: 3.627